CD19-directed chimeric antigen receptor T cell therapy in Waldenström macroglobulinemia: Initial experience in two clinical trials Meeting Abstract


Authors: Qualls, D.; Monette, S.; Sethi, S.; Dogan, A.; Roshal, M.; Senechal, B.; Wang, X.; Riviere, I.; Sadelain, M.; Brentjens, R.; Park, J.; Smith, E.; Palomba, M. L.
Abstract Title: CD19-directed chimeric antigen receptor T cell therapy in Waldenström macroglobulinemia: Initial experience in two clinical trials
Meeting Title: 10th Annual Meeting of the Society of Hematologic Oncology (SOHO)
Keywords: ct; therapy; waldenstrom macroglobulinemia; chimeric antigen receptor t cell; trial-in-progress
Journal Title: Clinical Lymphoma, Myeloma and Leukemia
Volume: 22
Issue: Suppl. 2
Meeting Dates: 2022 Sep 28-Oct 1
Meeting Location: Houston, TX
ISSN: 2152-2650
Publisher: Elsevier Inc.  
Date Published: 2022-10-01
Start Page: S443
Language: English
ACCESSION: WOS:000897948100543
PROVIDER: wos
DOI: 10.1016/s2152-2650(22)01664-0
Notes: Meeting Abstract: CT-329 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Renier J Brentjens
    286 Brentjens
  2. Maria Lia Palomba
    416 Palomba
  3. Jae Hong Park
    357 Park
  4. Sebastien Monette
    149 Monette
  5. Michel W J Sadelain
    583 Sadelain
  6. Isabelle C Riviere
    240 Riviere
  7. Xiuyan Wang
    119 Wang
  8. Eric Smith
    76 Smith
  9. Ahmet Dogan
    456 Dogan
  10. Mikhail Roshal
    232 Roshal
  11. David Augustus Qualls
    20 Qualls
  12. Shenon Sethi
    14 Sethi